AMERICAN CENTURY COMPANIES INC
Position in NTLA — Intellia Therapeutics, Inc.
CIK 748054
KANSAS CITY, MO
Position in NTLA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,044,150
+$1,373,732 QoQ
Shares Held
239,016
+14.7% QoQ
Ownership
0.171%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 330 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERICAN CENTURY COMPANIES INC holds $3,618,743,392 across 179 Biotechnology names. NTLA ranks #58 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,853,956 | $558,096,374 | |
| 2 | ASND |
Ascendis Pharma A/S
|
1,400,575 | $373,561,364 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
580,901 | $288,550,953 | |
| 4 | ARGX |
Argenx SE
|
173,193 | $160,683,269 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
1,947,076 | $154,383,656 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,791,664 | $97,484,438 | |
| 7 | HRMY |
Harmony Biosciences Holdings, Inc.
|
2,539,512 | $92,463,631 | |
| 8 | GPCR |
Structure Therapeutics Inc.
|
1,682,179 | $90,282,546 |
All Filings in NTLA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,044,150 | 239,016 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $2,670,418 | 208,301 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,720,236 | 191,350 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $4,320,349 | 250,165 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $3,844,711 | 409,884 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $3,353,616 | 471,676 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,291,552 | 453,821 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $9,009,859 | 438,436 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $7,396,903 | 330,514 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $7,344,179 | 266,964 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $7,577,649 | 248,529 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $8,449,275 | 267,213 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $10,290,833 | 252,350 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $13,062,948 | 350,495 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $11,565,476 | 331,484 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $15,004,163 | 268,123 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $10,979,434 | 212,122 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,348,366 | 73,598 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $8,816,329 | 74,563 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $9,618,420 | 71,699 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $9,972,360 | 61,592 | Shares | Defined | 2021-08-05 | |
| No filing history on record for this holder in this stock. | ||||||